Meta-Analysis of the Usefulness of Inferior Vena Cava Filters in Massive and Submassive Pulmonary Embolism

Ahmed, O.; Yu, Qian; Paul, Jonathan; Navuluri, Rakesh; Funaki, Brian; Ha, Thuong Van

doi:10.1016/j.amjcard.2020.05.001

Cited by 3 publications

(4 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several systematic reviews have illustrated the treatment effectiveness of IVCF. [26][27][28][29] A meta-analysis by Jiang et al has reviewed three RCTs and assessed the effectiveness of IVCF in reducing the risk of PE in patients with DVT. 26 They highlighted that IVCF combined with anticoagulation did not yield any benefits on the risk of short-term PE, DVT, and all-cause mortality compared with anticoagulation alone.…”

Section: Discussionmentioning

confidence: 99%

“…However, this study focused on patients with cancer-related venous thromboembolism, and studies under study included observational studies. A meta-analysis by Ahmed et al 29 included 15 observational studies and found that IVCF placement was associated with a reduced risk of recurrent PE and PE-related mortality in patients with massive and sub-massive PE. However, this study was based on observational studies, and selection and confounder biases were inevitable.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Efficacy and safety of vena cava filters in preventing pulmonary embolism: A systematic review and meta-analysis

Miao

Zhou

et al. 2023

Phlebology

View full text Add to dashboard Cite

Objectives To assess the treatment effectiveness of inferior vena cava filters (IVCF) versus non-IVCF for patients undergoing varies conditions. Methods We systematically searched the databases to identify eligible RCTs from their inception up to 9/20/2020. The primary endpoint was pulmonary embolism (PE), while the secondary endpoints included deep-vein thrombosis (DVT), major bleeding, and all-cause mortality. The RRs with 95% CIs were applied as effect estimates for the treatment effectiveness of IVCF versus non-IVCF and calculated by using the random-effects model. Results 1,137 patients of 5 RCTs were enrolled. There were no significant differences between IVCF and non-IVCF for the risk of PE, major bleeding, and all-cause mortality, while the risk of DVT was significantly increased for patients treated with IVCF. Conclusions The use of IVCF did not yield any benefits on PE, major bleeding, and all-cause mortality risk for patients undergoing various conditions, while the risk of DVT was significantly increased for patients treated with IVCF.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Efficacy and safety of vena cava filters in preventing pulmonary embolism: A systematic review and meta-analysis

Miao

Zhou

et al. 2023

Phlebology

View full text Add to dashboard Cite

show abstract

“…Patients who received filters were found to have a lower mortality rate (6.8% vs 26.3%) and a complication rate of 0.63%. Overall symptomatic PE recurrence was 1.4% [ 110 ]. This study suggests that IVC filters may be beneficial in the prevention of submassive or massive PE.…”

Section: Reviewmentioning

confidence: 99%

Inferior Vena Cava Filters and Complications: A Systematic Review

Bajda,

Park,

Raj

et al. 2023

Cureus

View full text Add to dashboard Cite

Inferior vena cava (IVC) filters have been used since the 1960s to treat patients with acute risk of pulmonary embolism (PE) to prevent migration of thrombus by trapping it within the filter. Traditional usage has been in patients with contraindication to anticoagulation that carry a significant mortality risk. In this systematic review, we sought to evaluate complications associated with placement of inferior vena cava filters based on published data from the past 20 years. A search was performed on October 6th, 2022, in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for systematic reviews, using three databases (ProQuest, PubMed and ScienceDirect) for articles published between the dates of February 1, 2002 and October 1, 2022. Results were filtered to include full-text, clinical studies, and randomized trials written in English pertaining to keywords “IVC filter AND complications”, “Inferior Vena Cava Filter AND complications”, “IVC filter AND thrombosis” and “Inferior Vena Cava Filter AND thrombosis”. Articles identified by the three databases were pooled and further screened for relevance based on inclusion and exclusion criteria. Initial search results yielded 33,265 hits from all three databases combined. Screening criteria were applied, with 7721 results remaining. After further manual screening, including removal of duplicate hits, a total of 117 articles were selected for review. While there are no consensus guidelines for best practice, there is compelling evidence that IVC filters can provide significant protection against PE with minimal complications if the treatment window is appropriate. Increase in the variety of filter models has led to broader availability, but skepticism remains about their efficacy and safety, with ongoing controversy surrounding appropriate indications. Further research is needed to establish clear guidelines on appropriate indications for IVC placement and to determine time course of complications versus benefits for indwelling filters.

show abstract

“…At present, inferior vena cava (IVC) filters have satisfactory clinical outcomes in preventing the development of PE and in reducing its associated mortality rates (3). In contrast, the placement of a VCF in the superior vena cava (SVC) for preventing PE caused by UEDVT is controversial (4).…”

Section: Introductionmentioning

confidence: 99%

Case Report: Pericardial Tamponade and Hemothorax After Superior Vena Cava Filter Removal

Zeng

Zhou

et al. 2022

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

A 67-year-old male patient was admitted to receive surgical treatment because of lumbar spinal stenosis. Ultrasonography showed a thrombus in the middle and lower segment of the left internal jugular vein. Superior vena cava filter implantation was performed and removed on day 7 after its implantation. The patient suddenly had dyspnea, and his blood pressure decreased 9 h after filter removal. Examinations showed pericardial tamponade and hemothorax. In addition, aortic dissection occurred approximately 20 days after superior vena cava filter removal. This case aimed to provide information to clinicians about the complications of the implantation and removal of superior vena cava filter implantation. The safety and possible complications of superior vena cava filter implantation and removal should be evaluated to identify their actual clinical benefit and cost-effectiveness ratio.

show abstract

Meta-Analysis of the Usefulness of Inferior Vena Cava Filters in Massive and Submassive Pulmonary Embolism

Cited by 3 publications

References 25 publications

Efficacy and safety of vena cava filters in preventing pulmonary embolism: A systematic review and meta-analysis

Efficacy and safety of vena cava filters in preventing pulmonary embolism: A systematic review and meta-analysis

Inferior Vena Cava Filters and Complications: A Systematic Review

Case Report: Pericardial Tamponade and Hemothorax After Superior Vena Cava Filter Removal

Contact Info

Product

Resources

About